Drapalin Pharmaceutical, German Rapper Antifuchs Team Up To Merge Cannabis Medicine with Music

in Culture

In the heart of Europe, German rapper Antifuchs is blending beats with beliefs to champion the cause of cannabis wellness. Inspired by her personal journey and the transformative power of cannabis, Antifuchs has crafted an anthem for the movement: a song about her favorite cannabis brand, Munich-based Drapalin Pharmaceuticals, a beacon of innovation in Germany’s medical cannabis landscape.

Together, they recently visited Lagom Pharmatech s.r.o in the Czech Republic, a supplier to Drapalin Pharmaceuticals, to film a music video to go with the rapper’s newest hit, “Drapalin”. Amidst a sea of green, they filmed a music video that’s as much a visual feast as it is a manifesto – a call to arms for the cannabis-curious and the healthcare revolutionaries alike.

The song is a powerful fusion of Antifuchs’s gritty, honest lyrics and Drapalin’s groundbreaking work in medical cannabis. This artistic collaboration aims to shatter stigmas and open minds, creating a musical track that deliberately attempts to dismantle long standing stigmas and challenge societal perceptions. Together, Antifuchs and Drapalin are scripting the soundtrack of a revolution in medical science and social attitude, advocating for a world where cannabis’s potential is fully realized and integrated into the fabric of modern medicine.

The Soundtrack for a New Era of Cannabis in Germany

The release of this music video is particularly significant, coming just after Germany’s landmark decision to legalize recreational cannabis, effective April 1, 2024. Adults in Germany will soon enjoy the freedom to use cannabis recreationally, marking a major shift in national policy. Amidst these changes, Drapalin, already a leader in the medical cannabis industry, continues to pioneer advancements in cannabis use for health purposes. With a strong commitment to uncovering and promoting the therapeutic benefits of cannabis, Drapalin has emerged as a key player …

Read More

Author: Cynthia Salarizadeh / High Times

Leave a Reply

Your email address will not be published.


Latest from Culture

0 $0.00
Go to Top